Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 37Recruiting 28Active not recruiting 28Terminated 8Unknown 6Withdrawn 5Not yet recruiting 5No longer available 1

Sponsor Class

OTHER 4FED 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 5Neoplasm Metastasis 1

Interventions

Gemcitabine 13Radiotherapy 12Androgen Antagonists 12Specimen Handling 11Magnetic Resonance Spectroscopy 10pembrolizumab 9Nivolumab 8toripalimab 7darolutamide 7Drug Therapy 7Radiosurgery 6Docetaxel 6Cystectomy 6enzalutamide 5apalutamide 5Mitomycin 5Cisplatin 5Axitinib 5Abiraterone Acetate 5disitamab vedotin 4cabozantinib 4abiraterone 4Pluvicto 4Cyclophosphamide 4tislelizumab 3lenvatinib 3fludarabine 3cemiplimab 3Sunitinib 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × apalutamide × Genitourinary × Clear all
NCT07333066 2026-01-12

REINFORCE

Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD

Phase 3 Not yet recruiting
320 enrolled
Genitourinary

Prostatic Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Medical University of Vienna

Not yet recruiting
500 enrolled
Genitourinary

Prostatic Neoplasms

NCT05778097 2023-03-21

ARES

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Not yet recruiting
103 enrolled
Genitourinary

Prostatic Neoplasms

NCT05717582 2023-02-08

CHAMPION

Fudan University

Phase 2 Not yet recruiting
47 enrolled
Genitourinary

Prostatic Neoplasms

NCT05422911 2022-06-21

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

James J. Peters Veterans Affairs Medical Center

Phase 2 Not yet recruiting
200 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡